🇺🇸 FDA
Patent

US 10525053

Abuse-deterrent pharmaceutical compositions of opioids and other drugs

granted A61KA61K31/13A61K31/135

Quick answer

US patent 10525053 (Abuse-deterrent pharmaceutical compositions of opioids and other drugs) held by Collegium Pharmaceutical, Inc. expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Collegium Pharmaceutical, Inc.
Grant date
Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/13, A61K31/135, A61K31/20, A61K31/4458